Navigation Links
QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen
Date:7/24/2014

AGEN-Produkten (einschließlich allgemeiner wirtschaftlicher Entwicklungen, Höhe und Verfügbarkeit der Budgets unserer Kunden und sonstiger Faktoren), Möglichkeit die regulatorische Zulassung für unsere Produkte zu erhalten, Schwierigkeiten bei der Anpassung von QIAGENs Produkten an integrierte Lösungen und die Herstellung solcher Produkte, die Fähigkeit des Unternehmens neue Produktideen zu entwickeln, umzusetzen und sich von den Produkten der Wettbewerber abzuheben sowie vor dem Wettbewerb zu schützen, Marktakzeptanz neuer Produkte, den Abschluss von Akquisitionen und die Integration akquirierter Geschäfte und Technologien. Weitere Informationen finden Sie in Berichten, die QIAGEN bei der U.S. Securities and Exchange Commission (US-Börsenaufsichtsbehörde) eingereicht hat.  

Kontakte:
Public Relations:
Dr. Thomas Theuringer
Director Public Relations
+49-2103-29-11826
E-Mail: pr@qiagen.com
http://www.twitter.com/qiagen


Investor Relations:
John Gilardi
Vice President Corporate Communications
+49-2103-29-11711
E-Mail: ir@qiagen.com



'/>"/>
SOURCE QIAGEN N.V.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. QIAGEN and Cardinal Health Collaborate to Offer Molecular Diagnostic Products to Smaller and Mid-sized U.S. Hospitals
2. QIAGEN Unveils Initiative to Create Next-Generation Sequencing Portfolio for use in Clinical Research and Molecular Diagnostics
3. QIAGEN Achieves Personalized Healthcare Milestone with U.S. Approval of Companion Diagnostic for Colorectal Cancer
4. QIAGEN Kicks Off Next-Generation Sequencing Initiative With Launch of a Series of Consumable Products to Improve NGS Workflows
5. QIAGEN Enters Into Broad Collaboration Agreement With Lilly for the Development and Commercialization of Companion Diagnostics
6. QIAGEN Expands Pipeline of Promising New Biomarkers for Development of Personalized Healthcare Companion Diagnostics
7. QIAGEN Significantly Expands its Offering of Assay Panels for Next-generation Sequencing (NGS) Complemented by Ingenuity Analysis and Interpretation Capabilities
8. Exosome Diagnostics and QIAGEN Partner to Launch Comprehensive Line of Biofluid Nucleic Acid Kits to Address Limitations of Tissue Biopsy in Clinical Research Market
9. Financial Results, Appointments, Earnings Conferences, and Partnerships - Research Report on New Oriental Education & Technology, Acacia Research, DeVry, Capella Education, and Qiagen NV
10. QIAGEN Offers Clinical Labs Early Access to New Ingenuity Solution for Streamlined Interpretation of Patient Sequencing Data
11. Maverix Biomics Forms Strategic Co-Marketing Alliance with QIAGEN
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... /CNW/ - The Canadian Pharmacists Association (CPhA) urges the federal ... that all Canadians have the opportunity to protect themselves ... immunization. The lack of access to HPV vaccination programs ... is needlessly putting the health of Canadians at risk. ... to pose a significant threat to the health of ...
(Date:7/6/2015)... July 6, 2015   BioClinica®, Inc ., ... today announced that it has acquired a leading ... , Inc. (Medici).  The acquisition includes affiliates ... Medici also provides a lost-to-follow-up patient locate service ...  Together with Medici, BioClinica will offer ...
(Date:7/6/2015)... Research and Markets( http://www.researchandmarkets.com/research/45v9b3/urinary_slings ... Slings Market in the US 2015-2019" report to ... Slings market in the US to grow at a ... This report covers the present scenario and the growth ... for the period 2015-2019. To calculate the market size, ...
Breaking Medicine Technology:CPhA Calls for HPV Strategy for Young Men to Save Lives 2BioClinica Acquires MediciGroup 2BioClinica Acquires MediciGroup 3United States Urinary Slings Market 2015-2019 - Vaginal Slings (TVT, TOT, and Single-incision) & Male Slings (Artificial Urinary Sphincters) 2
... England Journal of Medicine the B.E.S.T,study conducted in ... DISEASE CAN BE CONTROLLED,SUCCESSFULLY” , Prof. Fabbri: “Daily ... million 200 thousand people”.,Chiesi’s commitment to pneumological research ... to the daily dose,of cortisone necessary for the ...
... in AACR Cancer Journal , AUSTIN, Texas--(BUSINESS WIRE)--May ... of,data describing the dramatic clinical benefit of its ... inherited form of cancer known as,Li-Fraumeni Syndrome (LFS), ... p53 tumor suppressor gene. This is the,first reported ...
Cached Medicine Technology:Mild Asthma, a Revolutionary Therapy from Italian Research 2Mild Asthma, a Revolutionary Therapy from Italian Research 3Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer 2Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer 3Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer 4
(Date:7/7/2015)... ... 07, 2015 , ... On May 29, 2015, Health Canada announced that they ... gluten-free claims for gluten free oats and foods that contain them as ingredients. , ... (GFCP) to include gluten-free oat products in Canada,” says Frank Massong, VP of ...
(Date:7/7/2015)... ... ... Point is holding an onsite job fair to hire 400 people for its new site ... upcoming Wednesday, July 8, and Thursday, July 9, from 9:00 a.m. – 5:00 p.m. , ... well as holding onsite interviews. Interested parties are encouraged to attend the job fair ...
(Date:7/7/2015)... ... 07, 2015 , ... CSG Government Solutions, a ... the Department of Vermont Health Access to provide Quality Assurance (QA) and Independent ... Integrated Contact Center System project. , Vermont is implementing a strategic approach to ...
(Date:7/6/2015)... CA (PRWEB) , ... July 06, 2015 , ... For ... finding medical providers for personal injury victims. Throughout the company’s history the goal ... deliver the care victims need in their recovery. And while Doctors on Liens ...
(Date:7/6/2015)... ... July 06, 2015 , ... Human ... drug discovery. iPSCs are generated from adult cells, such as blood or skin, ... in the human body. , iPSC-derived cardiomyocytes have proven valuable ...
Breaking Medicine News(10 mins):Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 2Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 3Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 4Health News:Connexion Point, a tech enabled healthcare services company, is holding on-site job fair July 8th and 9th to fill 400 positions at its new Memphis location 2Health News:CSG Government Solutions Selected by the Department of Vermont Health Access to Provide Quality Assurance and Independent Verification and Validation Services 2Health News:Doctors on Liens Adds Transportation to Its Ever-Expanding Network 2Health News:Doctors on Liens Adds Transportation to Its Ever-Expanding Network 3Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 2Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 3Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 4
... 17, 2008 A new study in the Review ... meals at restaurants. Results show that both are larger and ... typical fast food meal being smaller and having fewer calories ... , James K. Binkley of Purdue University used data from ...
... , WASHINGTON, Dec. 17 ... A Call for Action: Enabling Healthcare Reform Using Information ... for the Obama Administration and 111th Congress to harness IT,s ... , "President-elect Obama and U.S. ...
... (SDSU) and the Moores Cancer Center at the University ... forces to help explain and eliminate cancer disparities. The ... Institute (NCI) of the National Institutes of Health will ... San Diego region with the goal of reducing differences ...
... 2008 - Elsevier, world-leading publisher of scientific, technical, and ... that, beginning in January 2009, the internationally respected ... ) (http://www.jpsmjournal.com) will be the official journal of the ... The JPSM will continue to serve as ...
... Therapeutics (Prime), a,nationwide pharmacy benefit management (PBM) company, ... as Chief Marketing Officer,(CMO). , ... , As ... marketing,strategy, product development and other market-related initiatives. He ...
... Frank, a medical doctor and,researcher at the University of ... remedy sickness and save lives should have access to the,best ... located near,research institutions in wealthy countries. , ... Frank,s idea led her to ...
Cached Medicine News:Health News:HIMSS Releases Health IT Blueprint for Obama Administration and Congress 2Health News:HIMSS Releases Health IT Blueprint for Obama Administration and Congress 3Health News:HIMSS Releases Health IT Blueprint for Obama Administration and Congress 4Health News:$15 million grant awarded to reduce cancer disparities 2Health News:$15 million grant awarded to reduce cancer disparities 3Health News:$15 million grant awarded to reduce cancer disparities 4Health News:Elsevier announces new partnership between the Journal of Pain and Symptom Management and the AAHPM 2Health News:Prime Therapeutics Hires Steven Blumenfield as Chief Marketing Officer 2Health News:Vivisimo Search Delivers Medical Knowledge to Global Health-Care Community 2
Inquire...
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
Inquire...
Medicine Products: